Real-world evidence on venetoclax in chronic lymphocytic leukemia: The Italian experience

Chronic lymphocytic leukemia (CLL) is the most common form of adult leukemia in the western world. In Italy, venetoclax was approved for use in patients with CLL as monotherapy in 2017 and in combinations in 2019. As a result of this delayed approval, there are relatively few real-world studies from...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Hematological oncology 2023-10, Vol.41 (4), p.621-630
Hauptverfasser:	Laurenti, Luca, Scarfò, Lydia, Frustaci, Anna Maria, Sanna, Alessandro, Iannella, Emilia, Caira, Morena, Finsinger, Paola, Schifano, Silvia, Neri, Benedetta, Molica, Stefano, Mauro, Francesca Romana
Format:	Artikel
Sprache:	eng
Schlagworte:	Bruton's tyrosine kinase Chronic lymphocytic leukemia COVID-19 Effectiveness Health risks Health services Immunological tolerance Kinases Leukemia Patients Protein-tyrosine kinase Rituximab Tyrosine
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!